We are proud to announce the return of our 13th annual
Controlled Release event to London in 2016!
Controlled-release (CR) drug-delivery systems continue to play an important role in the treatment of diseases.
With an increase prevalence of cancer globally and advanced developments in controlled release technologies,
controlled release remains the top priority for formulation scientists. Recent breakthroughs include the utilisation of nanotechnology and hydrogel polymers in controlled release mechanisms. In particular a long-acting insulin analogue shows promise for the treatment of diabetes, a unique approach which activates a micelle formation, facilitating transport of drug and significantly increasing absorption with a 10 to 50 fold increase in bioavailability.
Our 13th
Controlled Release 2016 event will engage you in lively discussions with industry leaders to discover the latest innovations, as well as guiding you through the latest regulatory updates to ensure strict compliance. Through the 2-day meeting, you will learn about up and coming novel controlled release strategies to accelerate commercialisation.
Benefits of Attending
- Discuss the latest innovations surrounding controlled release with case studies from GlaxoSmithKline, Ipsen and Merck
- Gain key regulatory updates from MHRA talking specifically on grey areas such as the regulatory environment surrounding combination products
- Join insightful discussions on nanotechnology from AstraZeneca and in depth discussions on QbD from UCB Pharma and Novo Nordisk
- Engage in our interactive sessions and speed networking to solidify your learning experience amongst your peers
Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 20th April 2016
A: QbD/PAT-Driven Controlled Release Design and Development08.30 – 12.30
Leaders: Jérôme Mantanus, Senior Scientist QbD/PAT Drug Product Formulation, UCB Pharma
Cristiana Campa, Head, Quality by Design Integration, GlaxoSmithKline
B: Exploring Controlled Release Drug Delivery Methods13.30 – 17.30
Leaders: Rene Holm, Senior Director, Lundbeck
Clive Wilson, Professor of Pharmaceutics, University of Strathclyde
Ijeoma Uchegbu, Chair in Pharmaceutical Nanoscience, University College London & CEO, Nanomerics
Speakers
- Andy Lewis, Director Novel Drug Delivery Technologies, Ipsen
- Anjumn Shabir-Ahmed, Head of Pharmaceutical Science, Critical Pharmaceuticals Limited
- Daniel Margetson, Director CMC, Diurnal
- Dario Carugo, Research Fellow, University of Oxford & University of Southhampton
- David Elder, Externalisation Director, GlaxoSmithKline
- Harpreet Sandhu, Senior Director, Kashiv Pharma
- Howard Stevens, Professor, University Of Strathclyde
- Inder Gulati, Formulation R&D Lead, Merck
- Jerome Mantanus, Senior Scientist QbD/PAT Drug Product Formulation, UCB Pharma
- Marianne Ashford, Principal Scientist Drug Targeting, AstraZeneca
- Marion Westwood, Pharmaceutical Assesor, MHRA
- Mark Wilson, Director Platform Technology and Science, GlaxoSmithKline
- Mohammad Absar, Pharmacologist, FDA
- Rene Holm, Senior Director, H Lundbeck A/S
- Sachin Mittal, Senior Principal Scientist, Merck
- Saif Shubber, Formualtion Scientist, MedImmune Inc.
- Samir Haddouchi, Managing Director, SPS Pharma Services
- Sune Andersen, Principal Scientist Drying Processes, Novo Nordisk A / S
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
You should attend this event if you are a Director, Area Head, Chief Executive, CSO, or Vice President within the pharmaceutical or healthcare industry with responsibilities in the following areas:
- Controlled release
- Drug delivery systems
- Analytical development
- Formulation development
- Pharmaceutical sciences
- Preclinical development
- Toxicology
- PK/PD
- Process development
- Regulatory affairs
- R&D
- Nanoparticles
- Software
Venue
Holiday Inn Regents ParkCarburton Street
London
W1W 5EE England
